[The antimicrobial effect of lysozyme on nasal mucosa].
We tested the effect of lysozyme on the nasal mucosa in a controlled double-blind in vivo study. The administration of non-pathogenic vaccine strains of living measles virus and of living Vivotif bacteria (attenuated Salmonella typhi) to 14 healthy subjects showed that lysozyme possesses a clear antimicrobial and antiviral effect.
Glück
U
U
Universitätsklinik für HNO-Krankheiten, Kantonsspital Basel.
D000281:Administration, Intranasal; D000328:Adult; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D006801:Humans; D008459:Measles virus / Q000187:drug effects*; D009113:Muramidase / Q000494:pharmacology*; D009297:Nasal Mucosa / Q000382:microbiology*; D012485:Salmonella typhi / Q000187:drug effects*
D009113:Muramidase
Zur antimikrobiellen Wirkung von Lysozym auf der Nasenschleimhaut.